Pleiotropic function of ezrin in human metastatic melanomas

International Journal of Cancer

Volumn 124, Issue 12, 2009, Pages 2804-2812

  Federici, Cristina ^a   Brambilla, Daria ^a   Lozupone, Francesco ^a   Matarrese, Paola ^a   De Milito, Angelo ^a   Lugini, Luana ^a   Iessi, Elisabetta ^a   Cecchetti, Serena ^a   Marino, Marialucia ^a   Perdicchio, Maurizio ^a   Logozzi, Mariantonia ^a   Spada, Massimo ^a   Malorni, Walter ^a   Fais, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

CD44; Lamp 1; Merlin; Organelle acidity; Phagocytic vacuole

Indexed keywords

EZRIN; HERMES ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MERLIN; CD44 PROTEIN, HUMAN; CROSS LINKING REAGENT; CYTOSKELETON PROTEIN; LAMP1 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN;

ACIDIFICATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; ANIMAL; DRUG SCREENING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELL; IMMUNOPRECIPITATION; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MELANOMA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKIN TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CROSS-LINKING REAGENTS; CYTOSKELETAL PROTEINS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MELANOMA; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEUROFIBROMIN 2; PHAGOCYTOSIS; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; VACUOLES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 65649091288     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24255     Document Type: Article

References (54)

1. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM Helman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004;10:182-186 (Pubitemid 38524889)
2. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-181 (Pubitemid 38524888)
3. Mäkitie T, Carpén O, Vaheri A Kivelä T. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthal Vis Sci 2001;42:2442-2449
4. Akisawa N, Nishimorib I, Iwamurac T, Onishib S Hollingsworth MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Comm 1999;258:395-400. (Pubitemid 29287062)
5. Weng WH, Ahlén J, Aström K, Lui WO Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005;11:6198-6204 (Pubitemid 41262948)
6. Slater M, Cooper M, Murphy CR. The cytoskeletal proteins alpha-actinin. Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Appl Immunohistochem Mol Morpho 2007;15:170-174
7. Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A Flores-Morales A. Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem 2006;281:29938-29948 (Pubitemid 44537002)
8. Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, Zha XL, Liu KD. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 2006;132:685-697 (Pubitemid 44337929)
9. Geiger KD, Stoldt P, Schlote W Derouiche A. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000;157:1785-1793
10. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Bio 2002;3:586-599 (Pubitemid 34886970)
11. Helander TS, Carpén O, Turunen O, Kovanen PE, Vaheri A Timonen T. ICAM-2, redistributed by ezrin as a target for killer cells. Nature 1996;382:265-268 (Pubitemid 26251363)
12. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmatic domain of CD 44. CD 43, and. ICAM-2. J Cell Biol 1998;140:885-895 (Pubitemid 28141226)
13. Gautreau A, Poullet P, Louvard D, Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:7300-7305 (Pubitemid 29299656)
14. Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F, Falchi M, Malorni W, Fais S. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J 2000;19:5123-5134 (Pubitemid 30765251)
15. Lozupone F, Lugini L, Matarrese P, Luciani F, Federici C, Iessi E, Margutti P, Stassi G, Malorni W, Fais S. Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J Biol Chem 2004;279:9199-9207 (Pubitemid 38295983)
16. Luciani F, Matarrese P, Giammarioli AM, Lugini L, Lozupone F, Federici C, Iessi E, Malorni W, Fais S. CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95(APO-1/Fas)-mediated apoptosis of human resting CD4(1)T lymphocytes. Cell Death Diff 2004;11:574-582
17. Charrin S, Alcover A. Role of ERM (ezrin-radixin-moesin) proteins in T lymphocyte polarization, immune synapse formation and in T cell receptor-mediated signaling. Front Biosci 2006;11:1987-1997. (Pubitemid 43253410)
18. Kishore R, Qin G, Luedemann C, Bord E, Hanley A, Silver M, Gavin M, Yoon YS, Goukassian D, Losordo DW. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclinA. J Clin Invest 2005;115:1785-1796 (Pubitemid 40979717)
19. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992;103:293-298
20. Vaheri A, Carpén O, Heiska L, Helander TS, Jääskelä inen J, Majander-Nordenswan P, Sainio M, Timonen T, Turunen O. The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Cell Biol 1997;9:659-666 (Pubitemid 27424922)
21. Okada T, Lopez-Lago M, Giancotti FG. Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 2005;171:361-371 (Pubitemid 41540027)
22. Sainio M, Jääskeläinen J, Pihlaja H, Carpén O. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH terminus. Neurology 2000;54:1132-1138 (Pubitemid 30151858)
23. Lugini L, Lozupone F, Matarrese P, Funaro C, Luciani F, Malorni W, Rivoltini L, Castelli C, Tinari A, Piris A, Parmiani G, Fais S. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin. Lab Invest 2003;83:1555-1567 (Pubitemid 37424017)
24. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, Gentile M, Luciani F, Parmiani G, Rivoltini L, Malorni W, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006;66:3629-3638
25. Sarafian V, Jadot M, Foidart JM, Letesson JJ, Van den Brûle F, Castronovo V, Wattiaux R, Coninck SW. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells. Int J Cancer 1998;75:105-111 (Pubitemid 28113984)
26. Tomlinson J, Wang JL, Barsky SH, Lee MC, Bischoff J, Nguyen M. Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol 2000;16:347-353
27. Chen JW, Cha Y, Yuksel KU, Gracy RW, August JT. Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco-differentiation antigens. J Biol Chem 1988;263:8754-8758 (Pubitemid 18163125)
28. Fukuda M, Viitala J, Matteson J, Carlsson SR. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and hlamp-2. Comparison of their deduced amino acid sequences. J Biol Chem 1988;263:18920-18928 (Pubitemid 19016352)
29. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 1991;266:21327-21330 (Pubitemid 121000182)
30. Youakim A, Romero PA, Yee K, Carlsson SR, Fukuda M, Herscovics A. Decrease in polylactosaminoglycans associated with lysosomal membrane glycoproteins during differentiation of CaCo-2 human colonic adenocarcinoma cells. Cancer Res 1989;49:6889-6895 (Pubitemid 20016562)
31. Pierce M, Arango J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J Biol Chem 1986;261:10772-10777
32. Kuźbicki L, Gajo B, Chwirot BW. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions. Melanoma Res 2006;16:235-243 (Pubitemid 44085097)
33. Laferte S, Dennis JW. Purification of two glycoproteins expressing beta 1-6 branched Asp-linked oligosaccharides from metastatic tumor cells. Biochem J 1989;259:569-576 (Pubitemid 19111695)
34. Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1992;267:5700-5711
35. Arterburn LM, Earles BJ, August JT. The disulfide structure of mouse lysosome associated membrane protein 1. J Biol Chem 1990;265:7419-7423 (Pubitemid 20162484)
36. Sawada R, Lowe JB, Fukuda M. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem 1993;268:12675-12681 (Pubitemid 23182432)
37. Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E, Steven A. Rosenberg. Induction of tumor-reactive. CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen. MART-1. J Immunol 1995;154:2257-2265
38. Lozupone F, Pende D, Burgio VL, Castelli C, Spada M, Venditti M, Luciani F, Lugini L, Federici C, Ramoni C, Rivoltini L, Parmiani G, et al. Effect of human natural killer and gd cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 2004;64:378-385 (Pubitemid 38114121)
39. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995-1001. (Pubitemid 35256475)
40. Riemann DA, Tcherkes GH, Hansen J, Wulfaenger TB, Danielsen EM. Functional co-localization of monocytic aminopeptidase N/CD13 with the Fc receptors CD32 and CD64. Biochem Biophys Res Commun 2005;331:1408-1412 (Pubitemid 40692512)
41. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003;197:1323-1334 (Pubitemid 36617779)
42. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994;126:391-401. (Pubitemid 24226255)
43. Bretscher A, Reczek D, Berryman M. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 1997;110:3011-3018 (Pubitemid 28026432)
44. Green NS, Reisler E, Houk KN. Quantitative evaluation of the lengths of homobifunctional protein cross-linking reagents used as molecular rulers. Prot Sci 2001;10:1293-1304 (Pubitemid 32568096)
45. Ajuh P, Kuster B, Joost K, Zomerdijk CBM, Mann M, Lamond AI. Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J 2000;19:6569-6581
46. Gary R, Bretscher A. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell 1995;6:1061-1075
47. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003;3:877-883
48. Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 2007;26:836-850 (Pubitemid 46245741)
49. Sun CX, Robb VA, Gutmann DH. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J Cell Sci 2002;115:3991-4000. (Pubitemid 35446798)
50. Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis. Mol Biol Cell 2000;11:467-480 (Pubitemid 30112158)
51. Bowman EJ, Bowman BJ. Purification of vacuolar membranes, mitochondria, and plasma membranes from Neurospora crassa and modes of discriminating among the different H1-ATPases. Methods Enzymol 1988;157:562-573
52. Ilmonen S, Vaheri A, Asko-Seljavaara S, Carpén O. Ezrin in primary cutaneous melanoma. Modern Pathol 2005;18:503-510 (Pubitemid 40478113)
53. Moilanen J, Lassus H, Leminen A, Vaheri A, Bützow R, Carpén O. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol oncol 2003;90:273-281 (Pubitemid 36952014)
54. Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Annu Rev Biochem 1978;47:819-846